Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17680158 | 0.98 | CYP2D6 (0.38) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL17678860 | 0.96 | TSHR (0.39) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL14498332 | 0.94 | CYP2D6 (0.38) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL14498333 | 0.94 | CYP2D6 (0.38) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL14498331 | 0.94 | CYP2D6 (0.38) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL7144350 | 0.94 | CYP2D6 (0.38) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL17069742 | 0.92 | CYP2D6 (0.37) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL14498334 | 0.88 | CYP2D6 (0.34) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL2022933 | 0.86 | CYP2D6 (0.35) | TSHRCYP2D6CYP2C19HIF1APRKCA | |
| SCHEMBL23095205 | 0.83 | DGAT1 (0.35) | PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947347-B2 | Hyrophilic ethylene oxide free emulsifier comprising dendrimeric polyhydroxylated ester moieties | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2021-03-16 | — | — | US | disclosed |
| US-9498973-B2 | Ink jet recording system | SEIKO EPSON CORPORATION (JP) | 2016-11-22 | — | — | US | disclosed |
| US-20160102179-A1 | HYROPHILIC ETHYLENE OXIDE FREE EMULSIFIER COMPRISING DENDRIMERIC POLYHYDROXYLATED ESTER MOIETIES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2016-04-14 | — | — | US | disclosed |
| US-20160016402-A1 | INK JET RECORDING SYSTEM | SEIKO EPSON CORPORATION (JP) | 2016-01-21 | — | — | US | disclosed |
| US-20120097194-A1 | Polymeric Coatings Incorporating Bioactive Enzymes for Catalytic Function | REACTIVE SURFACES, LTD. (US) | 2012-04-26 | — | — | US | disclosed |
| US-8153708-B2 | Process for forming a waterborne composite polyurethane/acrylic polymer dispersion | PPG INDUSTRIES OHIO, INC (US) | 2012-04-10 | — | — | US | disclosed |
| US-20110250626-A1 | Visual Assays for Coatings Incorporating Bioactive Enzymes for Catalytic Functions | REACTIVE SURFACES, LTD. (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110240064-A1 | Polymeric Coatings Incorporating Bioactive Enzymes for Cleaning a Surface | REACTIVE SURFACES, LTD. (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110245415-A1 | PROCESS FOR FORMING A WATERBORNE COMPOSITE POLYURETHANE/ACRYLIC POLYMER DISPERSION | PPG INDUSTRIES OHIO, INC. (US) | 2011-10-06 | — | — | US | disclosed |
| US-8008416-B2 | Curable alkoxycarbonylamino compositions, coatings, and methods | BASF COATINGS GMBH (DE) | 2011-08-30 | — | — | US | disclosed |
| EP-2324087-A2 | COATINGS AND SURFACE TREATMENTS HAVING ACTIVE ENZYMES AND PEPTIDES | McDaniel, Steven C. (US) | 2011-05-25 | — | — | EP | disclosed |
| US-20110083884-A1 | NOVEL POLYIMIDE PRECURSOR COMPOSITION AND USE THEREOF | KANEKA CORPORATION (JP) | 2011-04-14 | — | — | US | disclosed |
| US-20110061915-A1 | NOVEL RESIN COMPOSITION AND USE THEREOF | KANEKA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947347-B2 | Hyrophilic ethylene oxide free emulsifier comprising dendrimeric polyhydroxylated ester moieties | HAO2, PAOX, ELOVL1 | TSHR 4030/4885CYP2D6 1735/4885CYP2C19 1436/4885 |
| US-20160102179-A1 | HYROPHILIC ETHYLENE OXIDE FREE EMULSIFIER COMPRISING DENDRIMERIC POLYHYDROXYLATED ESTER MOIETIES | HAO2, PAOX, ELOVL1 | TSHR 4030/4885CYP2D6 1735/4885CYP2C19 1436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.